Different specificities of two aldehyde dehydrogenases from Saccharomyces cerevisiae var boulardii by Datta, Suprama et al.
Bioscience Reports (2017) 37 BSR20160529
DOI: 10.1042/BSR20160529
Received: 22 November 2016
Revised: 24 January 2017
Accepted: 26 January 2017
Accepted Manuscript Online:
26 January 2017
Version of Record published:
02 March 2017
Research Article
Different speciﬁcities of two aldehyde
dehydrogenases from Saccharomyces cerevisiae
var . boulardii
Suprama Datta1,2, Uday S. Annapure1 and David J. Timson2,3
1Department of Food Engineering and Technology, Institute of Chemical Technology (ICT), Matunga, Mumbai 400 019, India; 2School of Biological Sciences, Queen’s University
Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, U.K.; 3School of Pharmacy and Biomolecular Sciences, University of Brighton, Huxley Building, Lewes Road,
Brighton BN2 4GJ, U.K.
Correspondence: David J. Timson (d.timson@brighton.ac.uk)
Aldehyde dehydrogenases play crucial roles in the detoxification of exogenous and endoge-
nous aldehydes by catalysing their oxidation to carboxylic acid counterparts. The present
study reports characterization of two such isoenzymes from the yeast Saccharomyces cere-
visiae var. boulardii (NCYC 3264), one mitochondrial (Ald4p) and one cytosolic (Ald6p). Both
Ald4p and Ald6p were oligomeric in solution and demonstrated positive kinetic cooperativity
towards aldehyde substrates. Wild-type Ald6p showed activity only with aliphatic aldehy-
des. Ald4p, on the contrary, showed activity with benzaldehyde along with a limited range of
aliphatic aldehydes. Inspection of modelled structure of Ald6p revealed that a bulky amino
acid residue (Met177, compared with the equivalent residue Leu196 in Ald4p) might cause
steric hindrance of cyclic substrates. Therefore, we hypothesized that specificities of the
two isoenzymes towards aldehyde substrates were partly driven by steric hindrance in the
active site. A variant of wild-type Ald6p with the Met177 residue replaced by a valine was also
characterized to address to the hypothesis. It showed an increased specificity range and
a gain of activity towards cyclohexanecarboxaldehyde. It also demonstrated an increased
thermal stability when compared with both the wild-types. These data suggest that steric
bulk in the active site of yeast aldehyde dehydrogenases is partially responsible for control-
ling specificity.
Introduction
The multigene family of aldehyde dehydrogenases (EC 1.2.1.3) contributes primarily to acetaldehyde
detoxification through its oxidation to acetate [1]. Other physiological roles of aldehyde dehydrogenases
include lipid peroxidation [2], the metabolism of amino acids and biogenic amines [3,4], corticosteroids
[5], retinoids [6,7] and protein deglycation [8]. The superfamily also participate in detoxification of ex-
ogenous aldehydes from beverages, foods, industrial pollutants etc [9,10]. Mammalian aldehyde dehy-
drogenases are classified on the basis of kinetic mechanistic features into three classes of enzyme family:
ALDH1, ALDH2 and ALDH3 being the representative members with rate-limiting steps in NADH dis-
sociation, deacylation and hydride transfer respectively [11,12]. All three classes conform to an ordered
ternary complex kinetic mechanism in which the NAD(P)+ coenzyme binds first in the reaction sequence
[13].
ALDH superfamily members typically exhibit a broad substrate specificity and many of
them are able to oxidize several highly reactive aliphatic and aromatic aldehydes. Exogenous
aldehydes, whether intermediates or products, may be derived from the metabolism of drugs
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(e.g. ethanol, cyclophosphamide and ifosfamide) or substances present in the environment (i.e. smog, cigarette smoke
and vehicle exhaust fumes) or may even be introduced as such [9,14-17]. Endogenous aldehydes derive from the
metabolism of amino acids, biogenic amines, vitamins, steroids or lipids. Therefore, degradation of exogenous and
endogenous aldehydes is of utmost importance [9,10,18]. Hence, there is a need to understand the biochemistry of a
diverse range of aldehyde dehydrogenases.
Saccharomyces cerevisiae (budding yeast) aldehyde dehydrogenases have been classified into cytosolic and
mitochondrial enzymes. ALD2 (YMR170C), ALD3 (YMR169C), ALD4 (YOR374W), ALD5 (YER073W) and
ALD6 (YPL061W) are the five different gene products identified in these categories [19,20]. Two cytosolic (Ald2p
and Ald3p) and one mitochondrial (Ald5p) isoenzymes are the best studied ones. The constitutively expressed,
K+-activated Ald5p is reported to be involved in regulation or biosynthesis of electron transport chain components
and acetate formation [20-22]. Stress-induced expression of the cytosolic Ald2p and Ald3p is required for ethanol ox-
idation andβ-alanine synthesis [23].Cytosolic Ald6p (Mg2+ activated) andmitochondrialAld4p are less well studied,
and are reported to be involved in anaerobic growth and conversion of acetaldehyde into acetate [21,22,24,25]. Wang
et al. documented the substrate specificity of S. cerevisiaemitochondrial Ald4p (previously known as ALDH2) along
with human ALDH1 and ALDH2 towards various aliphatic and aromatic aldehydes [26]. The enzyme was demon-
strated to be active with a range of aliphatic aldehydes and a small number of cyclic or aromatic ones [26].
In the present study, we investigated the specificity of two yeast aldehyde dehydrogenases for linear/branched-chain
aliphatic aldehydes and cyclic/aromatic aldehydes as substrates. The genes encoding the mitochondrial and cytosolic
isoenzymes ALD4 and ALD6 were cloned from a fruit isolate of Saccharomyces cerevisiae var. boulardii, NCYC
3264 (formerly known as Saccharomyces boulardii) [27]. This yeast strain has attracted particular attention as a pro-
biotic and also for accelerating wound healing, although conclusive evidence of its effectiveness in these applications
is limited [28-31]. The strain produces a variety of molecules with antioxidant properties, including some aldehydes
and their oxidation products [32]. Given that genes encoding enzymes of the polypropanoid pathway appear to be
absent from the genome of S. cerevisiae var. boulardii, we reasoned that aldehyde dehydrogenases may be impor-
tant in the production of these compounds providing a further justification for studying their biochemical properties.
Recombinant Ald4p and Ald6p proteins from S. cerevisiae var. boulardii were expressed for functional character-
ization. Based on molecular models of the proteins, a hypothesis to explain the different substrate specificities was
advanced. A variant of Ald6p was also expressed to test this hypothesis.
Materials and methods
S. cerevisiae strains and growth conditions
S. cerevisiae var. boulardii NCYC 3264 strain was procured from National Collection of Yeast Cultures (Norwich,
U.K.). Cultures were grown in YEPD (1% yeast extract, 2% peptone and 2% glucose) medium at 30◦C.
Recombinant expression and puriﬁcation of Ald6p and Ald4p
Genomic DNAwas extracted from yeast cells using the YeaStar genomic DNA kit TM (Zymo Research Corp., U.S.A.).
The coding sequences for ALD6 and ALD4 were PCR-amplified from this NCYC 3264 genomic DNA. The primers
were designed based on the ORF of Saccharomyces sp. ‘boulardii’ whole genome shotgun sequence (available
at: http://www.ncbi.nlm.nih.gov/nuccore/?term=saccharomyces%20boulardii%20genome%20) [33]. The amplicons
were inserted into the Escherichia coli expression vector pET46 Ek/LIC (Merck-Millipore, Nottingham, U.K.) ac-
cording to the manufacturer’s instructions (note that this vector introduces bases coding for the amino acid sequence
MAHHHHHHVDDDDK at the 5’-end of the coding sequence). Correct insertion into the vector was verified by
PCR and by DNA sequencing (GATC, London, U.K.) of the insert.
The expression vector was used to transform competent E. coli RosettaTM (DE3) cells (Merck-Millipore) and
colonies resulting from this transformation were used to inoculate cultures (5 ml of LB medium supplemented with
100 μg ·ml−1 ampicillin and 34 μg ·ml−1 chloramphenicol), which were grown overnight at 37◦C with shaking. Each
culture was then diluted into 1 litre of LB (supplemented with 100 μg · ml−1 ampicillin and 34 μg ·ml−1 chloram-
phenicol), grown until A600 reached 0.6 to 1.0 (typically 5–6h) at 30◦C, followed by a slow induction by adding 1.3
mM IPTG overnight (12–16 h) at 16◦C. Cells were harvested by centrifugation (4200g for 15 min at room tempera-
ture), resuspended in cell resuspension buffer (50 mM HEPES–OH, pH 7.5, 150 mM NaCl, 10% (v/v) glycerol) and
stored frozen at −80◦C until the purification step.
For purification, cell suspensions were thawed, disrupted by sonication on ice (three pulses at 100 W for 30 s with
30 s gaps for cooling) and clarified by centrifugation (20000g for 20 min at 4◦C). The supernatant was applied to
a cobalt agarose column (1 ml, His-Select, Sigma, Poole, U.K.), which had been pre-equilibrated in buffer A (cell
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resuspension buffer, except 500 mM NaCl) and allowed to pass through by gravity. The column was washed twice
with 40ml of buffer A and the protein was elutedwith two 2ml aliquots of bufferC (buffer A plus 250mM imidazole).
Protein containing fractions were identified by SDS/PAGE and dialysed overnight at 4◦C against cell resuspension
buffer supplemented with 1 mM DTT. The concentration of Ald6p and Ald4p were determined by the method of
Bradford [34] using BSA as a standard. The purified fractions were frozen at −80◦C in 20 μl aliquots.
Amutation resulting in a change to the coding sequence of ALD6 (p.M177V) was generated by site-directed muta-
genesis using theQuikChangemethod [35]. The altered plasmid sequence was verified by Sanger sequencing (GATC,
London, U.K.) and transformed into E. coli RosettaTM(DE3) (Merck-Millipore) competent cells. Expression and pu-
rification were carried out using the same protocols as above.
Bioinformatics and molecular modelling
The well-studied human retinal dehydrogenase 1 [accession no: NP 000680.2] (class1) and liver mitochondrial
ALDH [accession no: CAG33272.1] (class 2) were identified using protein BLAST search. Multiple sequences of
the above mentioned ALDHs along with Ald4p and Ald6p sequences from the present study were aligned using
Transitive Consistency Score (TCS) web server available from http://tcoffee.crg.cat/tcs to determine their homol-
ogy and conservation of domain residues [36]. The sequence homology was evaluated using ESPript 3.0 available
at http://espript.ibcp.fr [37]. A BLOSUM50 matrix scoring the similarity and identity between the sequences was
computed using the MatGAT v2.01 application [38].
The predicted protein sequences of Ald4p and Ald6p were submitted to Phyre2 in the intensive mode to generate
an initial molecular monomeric model of the protein [39]. This model was then minimized and computationally
solvated using YASARA (http://www.yasara.org/minimizationserver.htm) [40]. To generate a tetrameric model, four
copies of the model were aligned (using PyMol) to the four subunits of sheep class 1 ALDH (PDB ID: 1BXS [41]),
which shares>90% protein sequence similarity with human retinal dehydrogenases ALDH1A1 (PDB ID: 4WB9 [42])
as judged by the Sequence Similarity Cutoff parameters in Protein Data Bank (PDB). The tetrameric structure was
saved in a new pdb file together with the NAD+ cofactors associated with each subunit. This tetrameric, cofactor
bound structure was then minimized using YASARA. To identify the aldehyde-binding site, the structure of human
mitochondrial aldehyde dehydrogenase complexed with crotonaldehyde was used (PDB: 1O01 [43]) and was aligned
to the tetrameric models of Ald4p and Ald6p. A new pdb file was generated for both Ald4p and Ald6p incorporating
crotanaldehyde, which was then minimized in YASARA. Subsequent models were generated with other aldehydes
(octanal and benzaldehyde) bound by overlaying the ‘new’ substrate over the aldehyde group and key atoms from the
carbon backbone, removing the ‘old’ substrate and reminimizing the complex inYASARA. Thesemodels are provided
as supplementary information.
Cross-linking
Cross-linking with bis(sulfosuccinimidyl) suberate (BS3, 50–800 μM) was carried out with 15 μM protein (diluted as
required in 100 mM sodium phosphate buffer, pH 7.4) in a total volume of 10 μl. Reactionmixtures were incubated at
30◦C for 30 min before addition of the cross-linker and then incubated at the same temperature for a further 35 min.
Reactions were stopped by addition of an equal volume of SDS-loading buffer (120 mM Tris/HCl, pH 6.8, 4% (w/v)
SDS, 20%(v/v) glycerol, 5% (w/v) Bromophenol Blue and 1% (w/v) DTT) and analysed by SDS/PAGE (10% gel).
Analytical gel ﬁltration
Ald6p (wild-type and p.M177V variant) and Ald4p (200 μl of a 60 μM purified protein aliquot) were chro-
matographed on a Sephacryl S-300 (Pharmacia) column (total volume,Vt = 65.2 ml; void volume,V0 = 15.1 ml) at a
flow rate of 1ml ·min−1. The columnwas equilibrated and developed in bufferG (50mMTris/HCl, 17mMTris-base,
150 mM sodium chloride, pH 7.4) [44-46]. Fractions (1 ml) were collected and analysed for protein content by mea-
suring the absorbance at 280 nm. Standard proteins (Thyroglobulin, 669 kDa; Albumin, 67 kDa; Chymotrypsinogen,
25 kDa and Ribonuclease A, 14 kDa) were used to calibrate the column. Their elution volumes (Ve) were used to
calculate Kav according to the equation:
Kav = (Ve − V0) / (Vt − V0)
Molecular masses were estimated by making use of the inverse, linear correlation between Kav and the logarithm
of the molecular mass [45].
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Enzyme kinetic analysis
Aldehyde dehydrogenase activity was measured at 30◦C using a ThermoScientific MultiskanTM Microplate spec-
trophotometer. For Ald6p, reactions contained 100 mM sodium phosphate buffer (pH 7.3), containing 40 μM
NADP+, 20 μM MgCl2 (Mg2+ has been previously identified as a cation activator of S. cerevisiae Ald6p and NADP+
as the enzyme’s preferred cofactor [47,48]) and varied concentrations of substrates ranging from 10–1200 μM. The
long-chain (C8–C13) and phenolic aldehydes were dissolved in 1.7% (v/v) DMSO as a solvent carrier; this solvent has
been previously shown to have little effect on the activity of aldehyde dehydrogenases [49,50]. Ald4p was assayed in
the same buffer containing 20 μM KCl, 0.4 mM NAD+, 5 mM EDTA and 1 mM PMSF. K+ has been shown to act
as a cation activator of S. cerevisiae Ald4p and this enzyme can function with either NAD+ or NADP+ as a cofactor
[48,51].
Steady-state kinetic data was obtained in triplicates from the same 96-well plate with readings taken every 5 s. The
initial, linear portion of the progress curvewas identified by visual inspection and fitted by linear regression to give the
initial rates (v) of change in absorbance at 340 nm. These rates were converted into molar units using the extinction
coefficient of NADH (6.22 mM−1 · cm−1) [52]. Rates of reactions were thus expressed as micromolar concentration
of NAD(P)H formed per second.
The kinetic parameters (Vmax, K0.5 and Hill coefficient, h) were obtained by plotting the rates of reaction against
substrate concentration and fitting the data to the equation below using non-linear regression as implemented in
GRAPHPAD PRISM 6.0 (GraphPad Software Inc, CA, U.S.A.). All points were weighted equally.
v = Vmax[S]h/
(
K h0.5 + [S]h
)
Where, Vmax is the maximum enzyme velocity, [S] is the concentration of substrate, K0.5 is the concentration
of substrate that produces a half-maximal enzyme velocity (analogous to the Michaelis–Menten constant, Km, in
non-cooperative enzymes) and h is the Hill coefficient [53,54].
Differential scanning ﬂuorimetry (DSF)
Enzyme aliquots were diluted in 50 mM HEPES, pH 7.3, to a concentration of 5–7 μM in a final volume of 20 μl.
Sypro Orange (10×; manufacturer’s concentration definition) was mixed well and added. Determination of ”melting
temperatures” (Tm) was done as previously described [46,55]. Cofactors (NADP+ or NAD+) and substrates were
added as appropriate. Substrates were initially dissolved in 100% DMSO and diluted in buffer R (50mM HEPES–OH,
pH 7.5, 150 mM NaCl, 10% (v/v) glycerol) as required. The concentration of DMSO never exceeded 1% (v/v).
Results and discussion
Sequence and predicted structure of Ald4p and Ald6p
Following PCR amplification of S. cerevisiae var. boulardii ALD4 andALD6, the coding sequences were determined
and deposited in GenBank (accession numbers: KX022008 and KT869135 for ALD4 and ALD6 respectively). Align-
ment of the coding sequences using the S. cerevisiae S288c genome as reference revealed single nucleotide difference
in the S. cerevisiae var. boulardii ALD4 sequence (1342C>T) and five differences in the S. cerevisiae var. boulardii
ALD6 sequence (294C>T, 487A>G, 753A>G, 813G>A, 894T>C). Only the 487A>G substitution inALD6 altered
the protein coding sequence, resulting in the replacement of the isoleucine at position 163 by a valine residue. No
difference was observed in the protein coded for by ALD4. Multiple sequence alignment revealed an overall approx-
imately 70% similarity (50% identity) between the human class 1 and 2 and both Ald4p and Ald6p (Supplemen-
tary Figure S1b), with conserved motifs equivalent of GXGXXG box at the Rossmann fold (residues ∼160–230) and
residues at the catalytic channel (residues ∼200–410) (Supplementary Figure S1a). Although Ald4p is reported to be
a mitochondrial enzyme in S. cerevisiae, it lacks a discernable targeting sequence (consensus: MLSLRQSIRFFKPA-
TRTLCSSRYLL at the N-terminus [56]), as does the variant studied here.
Using the derived protein sequences of S. cerevisiae var. boulardii Ald4p and Ald6p, molecular models were built
(Figure 1). As expected, these models show a high degree of similarity to other aldehyde dehydrogenase structures.
For example, Ald4p has RMSD of 0.720 A˚ over 10088 equivalent atoms when compared with sheep liver aldehyde
dehydrogenase (1BXS); Ald6p and this protein had an RMSD of 0.729 A˚ over 10476 equivalent atoms. Val163 in Ald6p
(which differs from the previously reported sequences of S. cerevisiae Ald6p) does not form part of the active site
and lies close to the oligomeric interface. It, therefore, seems unlikely that the conservative substitution of valine for
isoleucine in our sequence compared with the S. cerevisiae S288c genome has any functional consequence for the
enzyme.
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Figure 1. The predicted structure of S. cerevisiae var. boulardii Ald4p and Ald6p
(a) The overall fold of Ald4p is shown as a tetramer, with each subunit in a different colour. (b) A close up of the active site showing the
arrangement of the NAD+ cofactor and the aliphatic aldehyde substrate, octanal. Backbone corresponding to residues Pro181 to Ile202 is
also shown. (c) The overall fold of Ald6p is shown as a tetramer, with each subunit in a different shade of grey. (d) A close up of the active
site showing the arrangement of the cofactor and the aliphatic aldehyde substrate, octanal. Backbone corresponding to residues Pro162 to
Ile183 is also shown. In (b) and (d), a key structurally equivalent residue in the active site is shown (Leu196 in Ald4p and Met177 in Ald6p). Note
how the longer, bulkier methionine residue might sterically hinder non-aliphatic substrates.
Each subunit in Ald4p and Ald6p contains one active site and the residues forming each of these sites come from
one subunit only. In our model, the cofactor and the substrate lie end-to-end in the active site with the nicotinamide
ring of the cofactor orientated towards the aldehyde group of the substrate (in our models, the distance between
the cofactor and the aldehyde group appears too large for efficient catalysis. We, therefore, assume that there will
be some conformational changes in order to bring the two substrates closer together before the reaction can occur.
This change is unlikely to affect the identity of the residues interacting with the substrates). While the cofactor is
predicted to make many specific contacts with the enzyme, the aldehyde substrate appears to be located in a channel
lined mainly with highly conserved hydrophobic residues as previously described in class 1, 2 and 3 human ALDHs
[57-59].Consequently, there are few specific contacts between the protein and this substrate leading us to hypothesize
that bothAld4p andAld6p can accommodate a range of different aldehyde substrates. This is consistent with previous
observations on bacterial, fungal and higher eukaryotic aldehyde dehydrogenases [58-62]. We further noted that part
of the aldehyde-binding site in Ald6p is formed by two methionine residues (Met177 and Met178). The structurally
equivalent residues in Ald4p are Leu196 and Met197 (Figure 1b,d). We postulated that substitution of the less bulky,
hydrophobic leucine residue at this position in the aldehyde-binding pocket might enable Ald4p to accommodate
bulkier substrates such as cyclic, aromatic or branched chain aldehydes.
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Figure 2. SDS/PAGE expression proﬁles and puriﬁcation of (a) Ald4p (56.2 kDa), (b) Ald6p (54.4 kDa) and (c) Ald6p-M177V
(54.4 kDa) using RossettaTM (DE3) E. coli
M: molecular mass marker 14.4–116.0 kDa (sizes shown to the left of the gel); C: cell extract; IE: induced expression; S: sonicate; W1, W2:
affinity column wash; E1, E2: elutions (for details of buffers etc., see ‘Materials and methods’ section).
Expression and puriﬁcation of mitochondrial Ald4p, cytosolic Ald6p and
its variant Ald6p.M177V
Ald4p andAld6p (wild-type and variant Ald6p.M177V) could be expressed in, and purified from, E. coli cells (Figure
2). Typical yields of wild-type Ald6p and its variant were approximately 2 mg/l of bacterial cell culture (Figure 2b,c),
but the yield of Ald4p was typically less than 1 mg/l culture (Figure 2a).
The resolution of the protein samples on SDS/PAGE (10% gels) showed small amounts of Ald6p at approximately
four times the expected molecular mass (Figure 2b) suggesting the presence of some protein oligomers that are resis-
tant to separation by SDS andheat treatment.Heat and SDS-resistant oligomerization have been observed in a number
of other proteins [63,64]. The intensity of this band was not reduced by supplementation of the loading buffer with
additional DTT (2 mM, results not shown).
Both cytosolic and mitochondrial yeast aldehyde dehydrogenases are
oligomers
The ability of the three enzymes to form dimers and tetramers was further investigated using chemical cross-linking
with BS3 (Figure 3). Resolution of the cross-linked products by SDS/PAGE (10% gel) revealed bands corresponding
to an Ald6p dimer (∼110 kDa) and tetramer (∼220 kDa) (Figure 3b). However, the Ald6p.M177V variant showed
oligomerization even in the absence of BS3 suggesting increased oligomeric stability compared with the wild-type
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Figure 3. SDS/PAGE analysis of cross-linking of (a) Ald4p, (b) Ald6p and (c) Ald6p p.M177V with BS3
M: molecular mass marker 10.0–200.0 kDa (selected sizes shown to the left of the gel). U: untreated, purified ALDH; the remaining lanes
show proteins treated with 50, 200, 400, 600 and 800 μM BS3 as indicated.
protein. The intensity of these bands was greater following treatment with increasing concentrations of BS3 (Figure
3c). Oligomerization was also seen with Ald4p; however, neither discrete homodimer nor homotetramer forms were
detected by SDS/PAGE (Figure 3a). Similar patterns of oligomerization was seen when cross-linking was done with
1–3% (v/v) glutaraldehyde (results not shown).
Oligomers were also detected by gel filtration chromatography for bothAld4p andAld6p (Figure 4). Themolecular
mass ofAld6pwas estimated to be approximately 220 kDa,which corresponds to a tetrameric assembly. Themolecular
mass of Ald4p, on the other hand was estimated to be approximately 151 kDa suggesting a trimeric arrangement. A
non-tetrameric arrangement for an ALDH is unusual and our models of Ald4p show the protein as a tetramer. There
is some, limited previous evidence for trimeric forms of S. cerevisiae aldehyde dehydrogenases [65]. These studies
were based on crude extracts and are likely to represent a mixture of the isoenzymes now known to be present in this
species. In the present study, cross-linked species corresponding to dimers, trimers and tetramers were detected. It is
hard to imagine how the protein could exist as a trimer without substantial conformational changes, assuming that
the basic fold of the monomer has been predicted correctly. Therefore, we assume that either the protein exists largely
as a tetramer that runs anomalously in gel filtration chromatography or there is a dynamic equilibrium between a
dimer and a ‘dimer of dimers’. Anomalies in gel filtration can arise from interactions between the protein and matrix,
which retard the elution of the protein resulting in a lower estimated apparent molecular mass [66]. The previously
c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 4. Analytical gel ﬁltration elution proﬁles of (a) Ald4p (∼20 μM) and (b) Ald6p (∼60 μM)
The points represent individual A280 readings and the line represents a trend line fitted by GraphPad Prism. The SDS profile shows the eluted
fraction corresponding to the highest A280 read. (c) The calibration graph used for the estimation of molecular masses.
detected trimers may represent intermediates in the formation of tetramers. Human ALDH3 is known to exist largely
as a dimer due to an extended C-terminal tail that prevents tetramerization [67].However, S. cerevisiae var. boulardii
Ald4p lacks a C-terminal tail and, in our models, the shorter N-terminal extension did not appear to sterically hinder
the formation of tetramers since it lies on the exterior of the predicted structure.
Both Ald4p and Ald6p exhibit positive cooperativity, but the two enzymes
show markedly different substrate speciﬁcity
Both Ald4p and Ald6p are active aldehyde dehydrogenases demonstrating positive cooperativity towards their
aldehyde substrates (Table 1, Supplementary Figures S2, S3 and S4). This may be accounted for the stability of
multi-subunit configuration of these enzymes where binding of the substrate to the first subunit increases its affinity
for the subsequent subunits. Previously, positive cooperativity was reported in S. cerevisiae cytosolic aldehyde de-
hydrogenase for binding the cofactor NAD(P)+ following the substitution of an arginine residue with glutamate at
position 480 [68]. Interestingly, no observation for cooperative kinetics with respect to the aldehyde substrates has
previously been reported for yeast aldehyde dehydrogenases. The physiological significance of these cooperative ki-
netics with substrates is not yet known. In general, positively cooperative kinetics enable ‘switch-like’ responses to
changes in substrate concentrations and are commonly seen in enzymes and pathways that need to be highly sensi-
tive to small changes in substrate concentrations [69]. Ald6p showed activity with straight chain aliphatic aldehydes
ranging from C2 to C11 and the branched chain, C4 aldehyde, isobutanal. Once the chain length extended beyond 11
carbon atoms, no activity was detected. However, it should be noted that, as the chain length increases, the aldehydes
become less soluble in water and so the lack of activity may be partly explained by the failure of the compounds to
dissolve rather than failure to interact with the enzyme’s active site. Wild-type Ald6p showed no activity with any of
the cyclic or aromatic aldehydes tested. Interestingly, there was little correlation between activity and chain length,
with the highest activity (judged by the ratio of kcat toK0.5) being shown with propionaldehyde (Table 1). Like Ald6p,
Ald4p was active with a range of aliphatic aldehydes, with hexanal being the ‘preferred’ substrate from those tested
here. However, no activity could be detected with butyraldehyde (C4), not with any aldehydes with a chain length
greater than nine carbon atoms. In contrast with Ald6p, this enzyme was active with benzaldehyde, although it lacked
activity with the other cyclic and aromatic aldehydes tested (Table 1).
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Table 1 Apparent steady-state kinetic parameters for S. cerevisiae Ald4p and Ald6p with a range of substrates
Substrate Ald4p Ald6p Ald6p-pM177V
kcat (s−1) K0.5 (μM)
kcat/K0.5
(μM−1 · s) h kcat (s−1) K0.5 (μM)
kcat/K0.5
(μM−1 · s) h kcat (s−1) K0.5 (μM)
kcat/K0.5
(μM−1 · s) h
Acetaldehyde (2.91 +− 0.12)
× 10−3
20.32 +−
1.32
(1.43 +− 0.06)
× 10−4
3.27 +− 0.71 (1.51 +− 0.03)
× 10−2
205.3 +−
8.15
(7.38 +− 0.16)
× 10−5
1.87 +− 0.11 (3.92 +− 0.62)
× 10−3
49.13 +−
7.21
(7.98 +− 1.27)
× 10−5
3.08 +− 0.81
Propionaldehyde
(2.91 +− 0.10)
× 10−3
17.61 +−
1.16
(1.65 +− 0.06)
× 10−4
2.76 +− 0.46 (1.44 +− 0.12)
× 10−2
38.4 +− 5.14 (3.75 +− 0.33)
× 10−4
1.63 +− 0.18 (1.44 +− 0.66)
× 10−2
72.64 +−
37.41
(2.02 +− 0.92)
× 10−4
1.86 +− 0.53
Isobutyraldehyde
(5.25 +− 2.30)
× 10−3
81.71 +−
25.88
(6.43 +− 2.81)
× 10−5
1.26 +− 0.28 (7.56 +− 0.36)
× 10−3
91.00 +−
4.33
(9.01 +− 0.43)
× 10−5
3.72 +− 0.56 (7.5 +− 0.78)
× 10−3
37.00 +−
4.83
(2.02 +−
0.21) ×10−4
2.31 +− 0.44
Butyraldehyde –* –* –* –* (3.22 +− 0.09)
× 10−2
95.36 +−
2.79
(3.53 +− 0.10)
× 10−4
4.12 +− 0.42 –* –* –* –*
Valeraldehyde (3.22 +− 0.16)
× 10−3
30.21 +−
2.25
(1.06 +− 0.05)
× 10−4
2.00 +− 0.21 (3.41 +− 0.15)
× 10−3
21.32 +−
1.47
(1.6 +− 0.07)
× 10−4
2.39 +− 0.38 (1.21 +− 0.07)
× 10−2
37.17 +−
2.31
(3.26 +− 0.19)
× 10−4
4.88 +− 1.00
Hexanaldehyde (1.75 +− 0.05)
× 10−3
12.43 +−
0.79
(1.41 +− 0.04)
× 10−4
2.89 +− 0.51 (1.26 +− 0.38)
× 10−2
49.19 +−
6.48
(1.98 +− 0.06)
× 10−4
1.86 +− 0.51 (8.43 +− 0.58)
× 10−3
19.88 +−
2.15
(4.24 +− 0.29)
× 10−4
3.25 +− 1.14
Heptanaldehyde
(2.74 +− 0.13)
× 10−3
23.80 +−
1.61
(1.15 +− 0.05)
× 10−4
4.46 +− 1.34 (6.91 +− 2.24)
× 10−3
53.81 +−
21.8
(9.65 +− 3.13)
× 10−5
1.87 +− 0.58 (5.2 +− 0.18)
× 10−3
16.99 +−
1.13
(3.06 +− 0.11)
× 10−4
3.67 +− 0.77
Octanaldehyde (2.32 +− 0.08)
× 10−3
25.86 +−
1.16
(8.97 +− 0.31)
× 10−5
4.00 +− 0.71 (1.46 +− 0.06)
× 10−3
30.15 +−
6.67
(1.56 +− 0.07)
× 10−5
3.6 +− 2.56 –* –* –* –*
Nonanaldehyde
(2.52 +− 2.00)
× 10−3
72.97 +−
6.51
(3.46 +− 2.74)
× 10−5
1.86 +− 0.92 (1.74 +− 4.00)
× 10−2
288.5 +−
0.744
(6.06 +− 13.8)
× 10−5
1.24 +− 0.36 –* –* –* –*
Decyl aldehyde –* –* –* –* (3.27 +− 1.41)
× 10−3
52.62 +−
32.29
(6.22 +− 2.69)
× 10−5
1.61 +− 0.62 –* –* –* –*
Undecyl
aldehyde
–* –* –* –* (9.82 +− 2.80)
× 10−4
49.08 +−
13.65
(2.00 +− 0.57)
× 10−5
2.81 +− 1.20 –* –* –* –*
Dodecyl
aldehyde
–* –* –* –* –* –* –* –* –* –* –* –*
Tridecyl
aldehyde
–* –* –* –* –* –* –* –* –* –* –* –*
Crotonaldehyde
–* –* –* –* –* –* –* –* –* –* –* –*
Cyclohexane-
carboxyalde-
hyde
–* –* –* –* –* –* –* –* (6.93 +− 0.3)
× 10−3
26.97 +−
1.57
(2.57 +− 0.11)
× 10−4
2.66 +− 0.37
Benzaldehyde (9.16 +− 0.50)
× 10−4
20.29 +−
1.04
(4.51 +− 0.25)
× 10−5
7.83 +− 6.22† –* –* –* –* –* –* –* –*
4-hydroxy-
benzaldehyde
–* –* –* –* –* –* –* –* –* –* –* –*
Vanillin –* –* –* –* –* –* –* –* –* –* –* –*
DL-
glyceraldehyde
–* –* –* –* –* –* –* –* –* –* –* –*
Activity of yeast Ald6p and Ald6p–M177V was assayed using 100 mM sodium phosphate buffer (pH 7.3) at 30◦C containing 40 μM NADP+, 20 μM
MgCl2 (Mg2+ being the cation activator) and varied concentrations of substrates. Long-chain (C8–C13) and aromatic aldehydes were dissolved in 1.7%
(v/v) DMSO as a solvent carrier (see ‘Materials and methods’ section). Ald4p was assayed in the same reaction buffer containing 20 μM KCl (K+ acting
as cation activator), 0.4 mM NAD+, 5 mM EDTA and 1 mM PMSF.
*No detectable activity.
†This error is very high. Fitting of h by non-linear methods can be challenging since large changes in this parameter can greatly affect the others. This
value should be taken as evidence of positive cooperativity (which is also supported by the shape of the curve, Supplementary Figure S2) rather than a
deﬁnitive estimate.
Inspection of the molecular model of the active sites of Ald4p and Ald6p revealed a possible reason for these dif-
ferences in specificity. On one side of the Ald6p active site are two methionine residues (Met177 and Met178). These
bulky side chains protrude into the active site filling some of the volume potentially sterically hindering the binding
of a cyclic or aromatic substrate. In contrast, in Ald4p, the structurally equivalent residue was a leucine (Leu196). We,
therefore, reasoned that replacement of Met177 residue with a smaller valine residue might enable Ald6p to interact
with cyclic and/or aromatic aldehydes. Our hypothesis is supported by the sequence alignment with human alde-
hyde dehydrogenases (Supplementary Figure S1): both human ALDH1 and ALDH2, which are active with aliphatic
and cyclic aldehydes [26], have smaller amino acid residues (valine and leucine respectively) at the position corre-
sponding toMet177 in Ald6p. Furthermore, we have previously shown that an aldehyde dehydrogenase fromCandida
c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 2 Thermal stability (Tm) of S. cerevisiae var. boulardii Ald4p and Ald6p (WT and p.M177V variant)
Substrate or cofactor Tm (◦C)
Ald4p Ald6p Ald6p–M177V
Untreated 62.5 +− 0.0 62.5 +− 0.5 66.5 +− 0.2
NAD+ 63.1 +− 0.1* nd nd
NADP+ nd 63.9 +− 0.2* 63.5 +− 0.0*
Propionaldehyde 65.0 +− 0.2* 63.2 +− 0.7 66.7 +− 0.0
Valeraldehyde 65.5 +− 0.0* nd 67.0 +− 0.5
Octanal nd 62.7 +− 0.6 66.7 +− 0.6
Decanal 64.5 +− 0.5* 62.3 +− 0.3 65.8 +− 0.4*
Tridecanal nd 61.8 +− 0.0 66.0 +− 0.5
Crotonaldehyde 65.5 +− 0.1* 63.0 +− 0.5 67.0 +− 0.5
Cyclohexanecarboxaldehyde 63.5 +− 0.2* 61.2 +− 0.2* 65.7 +− 0.2*
Benzaldehyde 63.5 +− 0.2* 61.0 +− 0.5* 66.0 +− 0.0
4-hydroxybenzaldehyde 64.5 +− 0.3* 62.3 +− 0.5 66.5 +− 0.1*
Vanillin 64.5 +− 0.4* 62.5 +− 0.5 66.2 +− 0.5
Aldehyde substrates were measured with 2 mM substrate and cofactor (1.5 mM NAD+ for Ald4p, 2 mM NADP+ for Ald6p). Cofactors were measured
with 1.5 mM NAD+ for Ald4p and 2.0 mM NADP+ for Ald6p.
nd, not determined.
*Indicates a statistically signiﬁcant difference (P<0.05). Experiments with cofactors were compared with the appropriate untreated enzyme and experi-
ments with cofactor and aldehyde were compared with the appropriate one with cofactor only.
dubliniensis (which has an isoleucine at the equivalent position) is active with some cyclic and aromatic substrates
[70].
The Ald6p.M177V variant is active with aliphatic aldehydes and showed an increased activity with medium chain-
length aliphatic aldehydes (valeraldehyde and hexanaldehyde) comparedwith bothwild-typeAld4p andAld6p.How-
ever, its activity was only observed up to a chain length of seven carbons. Interestingly, it also gained activity with
cyclohexanecarboxaldehyde, a substrate that the wild-type enzyme has no activity towards (Table 1). However, even
with this change, there was no activity with benzaldehyde. This may be due to the lower reactivity of this aromatic
aldehyde. This suggests that our hypothesis is partially correct and that the creation of additional volume at this point
in the active site enables the binding and subsequent oxidation of bulkier aldehydes. However, the Ald6p.M177V
has no activity towards benzaldehyde (unlike Ald4p) suggesting that there are additional determinants of substrate
specificity in these enzymes. Ald6p.M177V, like Ald4p but not wild-type Ald6p, has no activity with butyraldehyde.
This suggests that a valine or leucine at the position equivalent to 177 in Ald6p is incompatible with the binding of
four carbon aldehydes. It is hard to provide a definitive explanation in the absence of an experimentally determined
structure. However, it may be that shorter aldehydes (with three or fewer carbons and isobutaraldehyde which is
branched) bind without significant interaction with this residue. The branched nature of valine or leucine may create
some steric hindrance to four carbon aldehydes, which can be overcome by the greater binding energy expected in
substrates with longer carbon chains.
Substrates and cofactors affect the thermal stability of yeast aldehyde
dehydrogenases
The Ald6p-M177V variant is more thermally stable than the wild-type with a melting temperature ∼4◦C higher
(Table 2, Supplementary Figure S5). This demonstrates that the M177V substitution increases the stability of the pro-
tein. Given that it was easier to detect oligomers in the variant (see above, Figure 3c), this most likely results from
tighter binding between the subunits of the oligomers. Ald4p has similar thermal stability to wild-type Ald6p (Table
2). NAD(P)+ binding caused a significant (P<0.05) increase in the Tm for Ald4p and wild-type Ald6p demonstrating
that this increases the overall stability towards heat denaturation of all three proteins (Table 2, Supplementary Figure
S5). Addition of the aldehyde substrates (in the presence of the appropriate cofactor) generally increased the thermal
stability of Ald4p, but most had little or no effect on Ald6p (Table 2, Supplementary Figure S5). Aldehyde dehydroge-
nases have an ordered, ternary complex mechanism in which NAD(P)+ binds first. These data suggest that cofactor
binding results in a small stabilization of the enzyme, perhaps due to a reorganization of the structure which then
permits aldehyde binding.
10 c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Conclusions
Both mitochondrial Ald4p and cytosolic Ald6p were observed to be prevalent in oligomeric configurations. Our
study also showed cooperativity of these enzymes towards aldehyde substrates, a phenomenon commonly observed
in oligomeric enzymes. Based on themolecularmodels, we hypothesized that the difference in specificity for aliphatic
and aromatic aldehydes was partly due to a bulky methionine residue partially sterically hindering the binding of
cyclic or aromatic substrates. Substitution of Met177 altered the specificity of Ald6p, suggesting that other alterations
to the sizes and properties of amino acids in this region of the proteinmay enable furthermodification of the substrate
range of aldehyde dehydrogenases.
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